Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 0.48%.

  • Ocular Therapeutix's Return on Capital Employed fell 900.0% to 0.48% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.48%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.46% for FY2025, which is 800.0% up from last year.
  • Ocular Therapeutix's Return on Capital Employed amounted to 0.48% in Q4 2025, which was down 900.0% from 0.66% recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Return on Capital Employed peaked at 0.23% during Q2 2024, and registered a low of 0.9% during Q2 2023.
  • Over the past 5 years, Ocular Therapeutix's median Return on Capital Employed value was 0.48% (recorded in 2025), while the average stood at 0.49%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 9800bps in 2021, then tumbled by -4100bps in 2023.
  • Over the past 5 years, Ocular Therapeutix's Return on Capital Employed (Quarter) stood at 0.42% in 2021, then plummeted by -52bps to 0.64% in 2022, then grew by 26bps to 0.48% in 2023, then rose by 17bps to 0.4% in 2024, then fell by -22bps to 0.48% in 2025.
  • Its Return on Capital Employed was 0.48% in Q4 2025, compared to 0.66% in Q3 2025 and 0.59% in Q2 2025.